Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Chronic consumption of a bergamot-based beverage does not affect glucose, lipid and inflammatory biomarkers of cardiometabolic risk in healthy subjects: a randomised controlled intervention study.
Maggiolo G, Aldigeri R, Savini C, Mengani M, Maggi M, Frigeri G, Spigoni V, Cinquegrani G, Fantuzzi F, Di Donna L, Tosi N, Bergamo F, Bresciani L, Rosi A, Mena P, Scazzina F, Del Rio D, Bonadonna RC, Dei Cas A. Maggiolo G, et al. Among authors: spigoni v. Food Funct. 2024 Jun 4;15(11):5842-5854. doi: 10.1039/d4fo00877d. Food Funct. 2024. PMID: 38767145 Clinical Trial.
Long-acting exenatide does not prevent cognitive decline in mild cognitive impairment: a proof-of-concept clinical trial.
Dei Cas A, Micheli MM, Aldigeri R, Gardini S, Ferrari-Pellegrini F, Perini M, Messa G, Antonini M, Spigoni V, Cinquegrani G, Vazzana A, Moretti V, Caffarra P, Bonadonna RC. Dei Cas A, et al. Among authors: spigoni v. J Endocrinol Invest. 2024 Sep;47(9):2339-2349. doi: 10.1007/s40618-024-02320-7. Epub 2024 Apr 2. J Endocrinol Invest. 2024. PMID: 38565814 Free PMC article. Clinical Trial.
Effect of coffee and cocoa-based confectionery containing coffee on markers of cardiometabolic health: results from the pocket-4-life project.
Martini D, Rosi A, Tassotti M, Antonini M, Dall'Asta M, Bresciani L, Fantuzzi F, Spigoni V, Domínguez-Perles R, Angelino D, Ricci C, Del Pozo-Luengo S, Tornel PL, Scazzina F, Gil-Izquierdo A, Dei Cas A, Brighenti F, Bonadonna R, Del Rio D, Mena P. Martini D, et al. Among authors: spigoni v. Eur J Nutr. 2021 Apr;60(3):1453-1463. doi: 10.1007/s00394-020-02347-5. Epub 2020 Jul 29. Eur J Nutr. 2021. PMID: 32728879 Free PMC article. Clinical Trial.
Sodium-glucose cotransporter 2 inhibitors antagonize lipotoxicity in human myeloid angiogenic cells and ADP-dependent activation in human platelets: potential relevance to prevention of cardiovascular events.
Spigoni V, Fantuzzi F, Carubbi C, Pozzi G, Masselli E, Gobbi G, Solini A, Bonadonna RC, Dei Cas A. Spigoni V, et al. Cardiovasc Diabetol. 2020 Apr 7;19(1):46. doi: 10.1186/s12933-020-01016-5. Cardiovasc Diabetol. 2020. PMID: 32264868 Free PMC article.
25 results